Follow up of Autoantibodies in Active Tuberculosis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00551226

Enrollment

Registered

2007-10-30

Start date

2007-11-30

Completion date

2008-11-30

Last updated

2007-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

TB, Patients with tuberculosis

Brief summary

We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Active Tuberculosis treated

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Follow up after levels of autoantibodies	1 year

Countries

Israel

Contacts

Primary ContactOri Elkayam, M.D

oribe14@netvision.net.il97236973668

Outcome results